NIH lab helps get vaccine from bench to bedside.
Traynor
Kate
K
D003218:Condylomata Acuminata / Q000276:immunology; D017277:Drug Approval; D015195:Drug Design; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D052162:Human papillomavirus 16 / Q000276:immunology; D052161:Human papillomavirus 18 / Q000276:immunology; D006801:Humans; D009316:National Institutes of Health (U.S.); D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000276:immunology*; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000517:prevention & control*; D014611:Vaccination
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines